ImmunoPrecise Antibodies (IPA) Misses Q4 EPS by 5c

ImmunoPrecise Antibodies (NASDAQ: IPA) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $6.98 million.

For earnings history and earnings-related data on ImmunoPrecise Antibodies (IPA) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Tellus Power and Nayax partner on integrated EV charging platform
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform